Literature DB >> 9757852

Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

R L Grubb1, C P Derdeyn, S M Fritsch, D A Carpenter, K D Yundt, T O Videen, E L Spitznagel, W J Powers.   

Abstract

CONTEXT: The relative importance of hemodynamic factors in the pathogenesis and treatment of stroke in patients with carotid artery occlusion remains controversial.
OBJECTIVE: To test the hypothesis that stage II cerebral hemodynamic failure (increased oxygen extraction measured by positron emission tomography [PET]) distal to symptomatic carotid artery occlusion is an independent risk factor for subsequent stroke in medically treated patients. DESIGN AND
SETTING: Prospective, blinded, longitudinal cohort study of patients referred from a group of regional hospitals between 1992 and 1996. PATIENTS: From 419 subjects referred, 81 with previous stroke or transient ischemic attack in the territory of an occluded carotid artery were enrolled. All were followed up to completion of the study, with average follow-up of 31.5 months. MAIN OUTCOME MEASURES: Telephone contact every 6 months recorded the subsequent occurrence of all stroke, ipsilateral ischemic stroke, and death.
RESULTS: Stroke occurred in 12 of 39 patients with stage II hemodynamic failure and in 3 of 42 patients without (P = .005); stroke was ipsilateral in 11 of 39 patients with stage II hemodynamic failure and in 2 of 42 patients without (P = .004). Six deaths occurred in each group (P = .94). The age-adjusted relative risk conferred by stage II hemodynamic failure was 6.0 (95% confidence interval [CI], 1.7-21.6) for all stroke and 7.3 (95% CI, 1.6-33.4) for ipsilateral stroke.
CONCLUSIONS: Stage II hemodynamic failure defines a subgroup of patients with symptomatic carotid occlusion who are at high risk for subsequent stroke when treated medically. A randomized trial evaluating surgical revascularization in this high-risk subgroup is warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9757852     DOI: 10.1001/jama.280.12.1055

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  170 in total

1.  Calculating percent stenosis.

Authors:  J Schwartz
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  Hemodynamic impairment and stroke risk: prove it.

Authors:  C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

3.  Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T.

Authors:  M Kavec; O H Gröhn; M I Kettunen; M J Silvennoinen; M Penttonen; R A Kauppinen
Journal:  MAGMA       Date:  2001-03       Impact factor: 2.310

4.  A default mode of brain function.

Authors:  M E Raichle; A M MacLeod; A Z Snyder; W J Powers; D A Gusnard; G L Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 5.  Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Authors:  Ananth K Vellimana; Andria L Ford; Jin-Moo Lee; Colin P Derdeyn; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

6.  Transient Ischemic Attack and Secondary Stroke.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

7.  Transient ischemic attack: are there different types or classes? Risk of stroke and treatment options.

Authors:  Hakan Ay; Walter J Koroshetz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

8.  Cerebral hemodynamics in carotid occlusive disease.

Authors:  Colin P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

Review 9.  Extracranial-intracranial arterial bypass for treatment of occlusion of the internal carotid artery.

Authors:  Robert L Grubb
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

10.  Susceptibility-weighted imaging predicts infarct size and early-stage clinical prognosis in acute ischemic stroke.

Authors:  Song Luo; Lijuan Yang; Yanfei Luo
Journal:  Neurol Sci       Date:  2018-03-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.